Lupin announced that it has acquired exclusive global rights to soft mist inhalation technology developed by Cambridge, UK design company TTP, and the two companies will co-develop the SMI device for delivery of inhaled drugs. Formulation development, regulatory submissions, commercial manufacturing, and commercialization of soft mist inhalers based on the TTP … [Read more...] about Lupin acquires rights to TTP’s SMI technology
News
Andrew Colin joins Beyond Air as Chief Medical Officer
Inhaled nitric oxide developer Beyond Air announced that pulmonologist Andrew Colin has been appointed as the company's Chief Medical Officer, effective December 1, 2021. Colin, who was most recently Chief of the Division of Pediatric Pulmonology at the University of Miami's Miller School of Medicine and Director of the university's Cystic Fibrosis Center, has … [Read more...] about Andrew Colin joins Beyond Air as Chief Medical Officer
Pharmascience to discontinue pms-sodium cromoglycate inhalation solution
Canadian pharma company Pharmascience has announced that it will stop manufacturing pms-sodium cromoglycate inhalation solution due to a 95% drop in demand over the past 15 years. Pharmascience now says it will sell pms-sodium cromoglycate for $24.23 per 50-nebule unit until it runs out of inventory. According to a November 19, 2021 Canadian news report, the … [Read more...] about Pharmascience to discontinue pms-sodium cromoglycate inhalation solution
Checking in with ISAM
By the ISAM board of directors As scientific leaders during a respiratory pandemic, the International Society for Aerosols in Medicine (ISAM) has been very busy over the past year, working to advance the understanding of aerosol medicine through the ISAM Journal (Journal of Aerosol Medicine and Pulmonary Drug Delivery), our 2021 Congress, a series of webinars, … [Read more...] about Checking in with ISAM
Team Consulting adds new laboratory space and re-opens to visitors
Following the lifting of government restrictions related to the COVID-19 pandemic, device design and development company Team Consulting is once again welcoming visitors to its headquarters in Cambridge, UK. Team has recently opened a new building at the Abbey Barns site, the company said, adding 5,500 sq ft of new laboratory space, workspaces, and design facilities. … [Read more...] about Team Consulting adds new laboratory space and re-opens to visitors
FDA approves Alembic’s generic formoterol fumarate inhalation solution
The FDA has approved Alembic Pharmaceuticals' ANDA for its formoterol fumarate inhalation solution, a generic of Mylan's Perforomist inhalation solution for the treatment of COPD, the company said. According to the announcement, this is the company's first US approval for an inhaled product. Alembic said that it worked with Indian contract research organization … [Read more...] about FDA approves Alembic’s generic formoterol fumarate inhalation solution
Janssen launches Spravato nasal spray in Australia
Janssen Pharmaceutical announced that it has launched Spravato esketamine nasal spray in Australia for the treatment of treatment-resistant depression following approval by the TGA. The company also said that will file a submission to the Pharmaceutical Benefits Advisory Committee (PBAC) for listing on the Pharmaceutical Benefits Scheme (PBS). Spravato is now … [Read more...] about Janssen launches Spravato nasal spray in Australia
Hovione to expand New Jersey facility
Particle engineering specialist Hovione, which recently announced plans to increase its global capacity by 25%, has announced that a portion of its $170 million expansion project will go toward a 31,000 sq ft building to add commercial spray drying capacity at its site in East Windsor, NJ, USA, with the new capacity expected to come online by 2023. The company also … [Read more...] about Hovione to expand New Jersey facility
Kindeva to install new MDI manufacturing line for filling lower GWP propellants
Kindeva Drug Delivery announced that it will install a new MDI manufacturing line capable of filling either HFA-152a or HFO-1234ze, both of which have a lower global warming potential (GWP) than HFA 134a. The new line is expected to be in place by the end of 2022, and the company said that it plans to launch two MDIs formulated with the lower GWP propellants by … [Read more...] about Kindeva to install new MDI manufacturing line for filling lower GWP propellants
FDA clears IND for Phase 2 study of Tonix’s intranasal oxytocin for the prevention of migraine
According to Tonix Pharmaceuticals, the FDA has cleared the company's IND for a Phase 2 study of TNX-1900 potentiated oxytocin nasal spray for the prevention of migraine headache. Tonix acquired the rights to the intranasal oxytocin for the treatment of migraine from Trigemina in June 2020 and says that it would plan to submit an NDA under the 505(b)(2) pathway. Over … [Read more...] about FDA clears IND for Phase 2 study of Tonix’s intranasal oxytocin for the prevention of migraine